PT1399448E - Derivados de imidazol[1,5-a]pirimido[5,4-d]benzazepina como moduladores do receptor gaba a - Google Patents

Derivados de imidazol[1,5-a]pirimido[5,4-d]benzazepina como moduladores do receptor gaba a

Info

Publication number
PT1399448E
PT1399448E PT02771640T PT02771640T PT1399448E PT 1399448 E PT1399448 E PT 1399448E PT 02771640 T PT02771640 T PT 02771640T PT 02771640 T PT02771640 T PT 02771640T PT 1399448 E PT1399448 E PT 1399448E
Authority
PT
Portugal
Prior art keywords
pyrimido
gaba
imidazol
receptor modulators
benzazepine derivatives
Prior art date
Application number
PT02771640T
Other languages
English (en)
Portuguese (pt)
Inventor
Raffaello Masciadri
Jurgen Wichmann
Andrew William Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PT1399448E publication Critical patent/PT1399448E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT02771640T 2001-05-18 2002-05-08 Derivados de imidazol[1,5-a]pirimido[5,4-d]benzazepina como moduladores do receptor gaba a PT1399448E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
PT1399448E true PT1399448E (pt) 2005-03-31

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02771640T PT1399448E (pt) 2001-05-18 2002-05-08 Derivados de imidazol[1,5-a]pirimido[5,4-d]benzazepina como moduladores do receptor gaba a

Country Status (37)

Country Link
US (1) US6686352B2 (https=)
EP (1) EP1399448B1 (https=)
JP (1) JP4068466B2 (https=)
KR (1) KR100533406B1 (https=)
CN (1) CN1230436C (https=)
AR (1) AR033753A1 (https=)
AT (1) ATE283857T1 (https=)
AU (1) AU2002338898B2 (https=)
BG (1) BG108369A (https=)
BR (1) BR0209859A (https=)
CA (1) CA2446903C (https=)
CZ (1) CZ20033355A3 (https=)
DE (1) DE60202147T2 (https=)
DK (1) DK1399448T3 (https=)
EC (1) ECSP034851A (https=)
ES (1) ES2232778T3 (https=)
GT (1) GT200200087A (https=)
HR (1) HRP20030890A2 (https=)
HU (1) HUP0400743A3 (https=)
IL (2) IL158572A0 (https=)
JO (1) JO2297B1 (https=)
MA (1) MA27024A1 (https=)
MX (1) MXPA03010529A (https=)
MY (1) MY127570A (https=)
NO (1) NO20035104L (https=)
NZ (1) NZ529097A (https=)
PA (1) PA8545201A1 (https=)
PE (1) PE20030041A1 (https=)
PL (1) PL366846A1 (https=)
PT (1) PT1399448E (https=)
RU (1) RU2287531C2 (https=)
SI (1) SI1399448T1 (https=)
SK (1) SK15252003A3 (https=)
TW (1) TWI251489B (https=)
WO (1) WO2002094834A1 (https=)
YU (1) YU90003A (https=)
ZA (1) ZA200308544B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540987T3 (es) 2004-05-14 2015-07-15 Millennium Pharmaceuticals, Inc. Métodos para preparar inhibidores de la aurora cinasa
AU2005294575B2 (en) * 2004-10-04 2011-11-24 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
AU2005299031B2 (en) * 2004-10-20 2011-11-10 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
KR101009860B1 (ko) * 2005-10-11 2011-01-19 에프. 호프만-라 로슈 아게 이미다조 벤조다이아제핀 유도체
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
US7998952B2 (en) 2008-12-05 2011-08-16 Millennium Pharmaceuticals, Inc. Thiolactams and uses thereof
RU2535032C2 (ru) 2008-12-22 2014-12-10 Милленниум Фармасьютикалз, Инк. Сочетание ингибиторов аврора киназы и анти-cd 20 антител
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
CA2788774A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3083569B1 (en) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP6987384B2 (ja) 2015-06-19 2021-12-22 エージンバイオ, インコーポレイテッド ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11414425B2 (en) 2018-06-19 2022-08-16 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (https=) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
WO1999043682A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives, their preparation and their use as (ant-)agonists for gaba (a) brain receptors
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
CN1390217A (zh) 1999-11-12 2003-01-08 神经原公司 二环和三环杂芳族化合物
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
KR100533406B1 (ko) 2005-12-02
PE20030041A1 (es) 2003-02-07
WO2002094834A1 (en) 2002-11-28
ZA200308544B (en) 2005-01-31
EP1399448A1 (en) 2004-03-24
YU90003A (sh) 2006-08-17
HRP20030890A2 (en) 2005-08-31
IL158572A (en) 2010-02-17
AU2002338898B8 (en) 2002-12-03
NO20035104D0 (no) 2003-11-17
SK15252003A3 (sk) 2004-08-03
JO2297B1 (en) 2005-09-12
US20030055042A1 (en) 2003-03-20
IL158572A0 (en) 2004-05-12
DE60202147D1 (de) 2005-01-05
MY127570A (en) 2006-12-29
JP2004531563A (ja) 2004-10-14
AU2002338898B2 (en) 2007-03-15
ECSP034851A (es) 2003-12-24
SI1399448T1 (en) 2005-02-28
HUP0400743A3 (en) 2007-09-28
CA2446903A1 (en) 2002-11-28
BG108369A (bg) 2005-01-31
PA8545201A1 (es) 2003-02-28
CN1230436C (zh) 2005-12-07
US6686352B2 (en) 2004-02-03
MA27024A1 (fr) 2004-12-20
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
TWI251489B (en) 2006-03-21
HUP0400743A2 (hu) 2004-07-28
CN1509289A (zh) 2004-06-30
RU2287531C2 (ru) 2006-11-20
GT200200087A (es) 2003-06-19
ES2232778T3 (es) 2005-06-01
DK1399448T3 (da) 2005-04-11
JP4068466B2 (ja) 2008-03-26
DE60202147T2 (de) 2005-12-01
CA2446903C (en) 2008-12-30
EP1399448B1 (en) 2004-12-01
NO20035104L (no) 2003-11-17
KR20040002975A (ko) 2004-01-07
AR033753A1 (es) 2004-01-07
RU2003136078A (ru) 2005-05-27
BR0209859A (pt) 2004-06-15
ATE283857T1 (de) 2004-12-15
CZ20033355A3 (en) 2004-07-14
HK1066544A1 (en) 2005-03-24
PL366846A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
PT1399448E (pt) Derivados de imidazol[1,5-a]pirimido[5,4-d]benzazepina como moduladores do receptor gaba a
DK1686130T3 (da) Pyrrolo-[2,3-d]-pyrimidinforbindelser som immunsuppressive midler
TWI346664B (en) Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a] pyrimidin-6-one derivatives
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
IS6383A (is) Pýrróló [2,3-d]pýrimidín efnasambönd
DE60016615D1 (de) Pyrazolo[4,3-d]pyrimidinderivate
DE59903421D1 (de) Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-on
PL1761542T3 (pl) Pochodne oktahydropirolo[3,4-c]pirolu i ich zastosowanie jako środków przeciwwirusowych
PL370535A1 (en) Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
DK1430057T3 (da) Substituerede 2-pyridinyl-6,7,8, 9-tetrahydropyrimido [1,2-a] pyrimidin-4-on- og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)onderivater
DE60103909D1 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
DK1210349T3 (da) Pyrazolo[4,3-d]pyrimidiner
PL1678182T3 (pl) Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
HUP0401991A3 (en) Method for producing of substituted imidazo[1,2-a]-5,6,7,8-tetrahydropyridine-8-on derivatives
IL173347A0 (en) 7-SUBSTITUTED 3-NITRO-PYRAZOLO[1,5-a] PYRIMIDINES
HK1084664A (en) Pyrazolo [1,5-a] pyrimidine derivatives
HK1068632A (en) Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents
HK1115380A (en) Pyrazolo [3, 4-d] azepine derivatives as histamine h3 antagonists